VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD)

Historical Holders from Q1 2016 to Q4 2025

Type / Class
Equity / SHRT HGH YLD MUN
Symbol
SHYD
Price per share
$22.91
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
10,192,547
Total reported value
$233,327,044
% of total 13F portfolios
0%
Share change
+17,534
Value change
+$487,039
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
131
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD) has 131 institutional shareholders filing 13F forms. They hold 10,192,547 shares. .

Institutional Holders of VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 548,471 $12,566,304 -$96,832 2,291% 8
2025 Q3 10,192,547 $233,327,044 +$487,039 2,290% 131
2025 Q2 10,126,619 $228,720,824 +$11,154,960 2,258.92% 129
2025 Q1 9,566,858 $215,125,672 +$6,885,166 2,249% 120
2024 Q4 9,396,480 $211,258,799 +$9,751,547 2,248% 125
2024 Q3 8,909,672 $202,402,767 -$1,053,963 2,272% 116
2024 Q2 8,875,499 $198,528,389 -$7,564,000 2,237% 112
2024 Q1 9,168,215 $205,427,631 -$23,956,421 2,241% 106
2023 Q4 10,278,899 $227,451,634 +$10,405,892 2,213% 119
2023 Q3 9,718,105 $210,090,133 -$1,808,132 2,162% 109
2023 Q2 9,756,447 $217,568,386 +$2,520,488 2,230% 107
2023 Q1 9,623,412 $214,519,159 -$6,636,472 2,229% 110
2022 Q4 9,923,778 $221,171,485 -$5,192,513 2,227% 107
2022 Q3 10,064,832 $219,273,531 -$8,869,906 2,176.89% 101
2022 Q2 10,421,287 $234,148,365 +$35,389,105 2,245.93% 102
2022 Q1 8,820,177 $205,232,466 +$13,273,275 2,325.89% 101
2021 Q4 8,141,253 $204,743,214 -$2,802,724 2,514.88% 110
2021 Q3 8,148,102 $204,518,481 +$43,370,524 2,510% 98
2021 Q2 6,418,663 $162,311,214 +$28,751,483 2,545.09% 93
2021 Q1 5,277,974 $132,091,961 +$28,070,512 2,502.5% 87
2020 Q4 4,152,598 $103,004,254 -$1,697,549 2,480.08% 73
2020 Q3 4,212,793 $102,677,662 -$11,333,542 2,437.99% 68
2020 Q2 4,667,416 $111,213,168 -$48,800,573 2,382.13% 67
2020 Q1 6,496,591 $146,248,835 +$38,177,787 2,251% 71
2019 Q4 5,012,099 $126,326,193 +$22,698,966 2,520.11% 72
2019 Q3 4,376,431 $110,199,083 +$9,825,487 2,517.91% 63
2019 Q2 3,953,833 $99,007,328 +$6,629,321 2,504.1% 60
2019 Q1 3,742,501 $92,440,015 +$17,151,731 2,469.92% 55
2018 Q4 3,028,375 $73,385,143 -$4,699,882 2,420.04% 51
2018 Q3 2,875,953 $69,911,719 +$2,042,275 2,430.96% 48
2018 Q2 2,791,046 $68,420,934 +$18,923,785 2,451.73% 44
2018 Q1 1,998,408 $48,376,265 +$1,602,184 2,420.79% 42
2017 Q4 1,932,326 $46,757,129 +$1,860,479 2,419.19% 39
2017 Q3 1,847,931 $45,198,000 -$1,524,595 2,445.76% 31
2017 Q2 1,910,512 $46,386,000 -$4,439,837 2,427.91% 36
2017 Q1 2,094,438 $50,279,000 -$20,757,757 2,400.89% 34
2016 Q4 2,960,434 $70,417,000 +$9,324,620 2,379.06% 36
2016 Q3 2,269,302 $57,301,000 +$4,821,082 2,525.12% 24
2016 Q2 2,139,169 $54,435,000 +$52,772,710 2,544.97% 28
2016 Q1 61,538 $1,530,000 +$718,000 2,487.86% 2